The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

What biosecurity risks do exo-microorganisms pose?

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Implementing green practices in clinical trials.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Researchers create micro-feeder that eases the handling of small quantities of powder.

When following COVID-19 research, it’s hard to keep your eye on the ball...